Effect of a Cisplatin Cross-Link on Nucleosome Structure
A R T I C L E S
proteins, such as chromatin isolation, purification, and histone transfer,
were carried out at 4 °C or on ice if not otherwise noted. Dialysis
membranes were obtained from Spectra/Por and treated with hot 50
mM EDTA solution, followed by treatment with 10 mM mercapto-
ethanol and several washes with high-purity water with a conductivity
of >12 MΩ before use to remove trace divalent cations. Denaturing
DNA polyacrylamide gel electrophoresis (PAGE) was performed on a
Life Technologies S2 sequencing gel electrophoresis apparatus. For
native DNA and nucleosome gel electrophoresis, a Protean II xi cell
from BioRad was used. Fluorescent agarose electrophoresis gels were
documented on a BioRad Fluor-S MultiImager. Electrophoresis gels
with radioactive samples were dried and documented on a Storm 840
Phosphorimager system from Amersham or exposed wet to a Kodak
Biomax MS film. Radioactive samples were quantified on a Beckman
LS 6500 scintillation counter. Fast protein liquid chromatography was
performed with a system from Amersham (P1 peristaltic pump and a
programmable Frac-100 fraction collector).
hydroxyl radical footprinting and exonuclease III mapping. In
comparison to structural studies of nucleosomes containing the
related 1,3-d(GpTpG) cisplatin cross-link, we identified some
similarities but also major differences. Most interesting is the
hyper-reactivity of the DNA toward hydroxyl radicals near the
d(GpG) cross-link which, together with greater structural
flexibility, indicates a distortion of the DNA that was not evident
for the 1,3-d(GpTpG) cross-link. The two different cisplatin
adducts also influence the translational setting in a different
fashion.
Our nucleosome studies to date have been focused on cis-
{Pt(NH3)2}2+ cross-links that are induced by the drugs cisplatin
or carboplatin. The more recently approved platinum-based
anticancer drugs oxaliplatin and tetraplatin, as well as com-
pounds currently under development, react with DNA to form
adducts that carry pendant ligands different from ammonia. The
effect of these so-called “carrier ligands”, which are present in
cis-{Pt(R,R-DACH)}2+ cross-links, where R,R-DACH is the
R,R-stereoisomer of 1,2-diaminocyclohexane present in oxali-
platin, or in DNA adducts of monofunctional complexes such
as {Ptpy(NH3)2)}2+, on the nucleosome structure is unknown
and will be the subject of future research. Additional studies
will also endeavor to elucidate the biological consequences of
nucleosomal platination, including damage recognition, repair,
and interference with transcription.
Synthesis of Platinated Oligonucleotides. First, eight oligonucle-
otides, a, b1, b2, c, d, e1, e2, and f, the sequences of which are provided
in Scheme S2 (Supporting Information), were chemically synthesized
and purified by preparative PAGE in the presence of 7.5 M urea. The
oligonucleotides were ethanol precipitated and desalted with SepPak
C18 cartridges. The purified strands were characterized by MALDI-
TOF mass spectrometry and quantified by UV/vis spectroscopy. The
two 21-mer oligonucleotides b1 and b2 were converted into b1-Pt
and b2-Pt by introduction of specific cis-{Pt(NH3)2}2+ 1,2-d(GpG)
intrastrand cross-links according to published procedures.43 The
platinated strands were purified by semipreparative HPLC, and the
quality of the fractions was monitored by analytical HPLC. The pure
fractions were pooled and concentrated by ethanol precipitation. The
rb values of the 21-mers b1-Pt and b2-Pt were determined to be 0.98/
21 and 1.05/21, respectively, corresponding to one cisplatin adduct per
oligonucleotide.
Experimental Section
Materials and Methods. Chemical reagents and solvents were
purchased from commercial sources. Cisplatin was synthesized from
K2[PtCl4] according to a published procedure.40 γ-32P-ATP having a
specific activity of at least 6000 Ci/mmol was obtained from Perkin-
Elmer (Boston, MA) and used on the day of arrival. DNA synthesis
was conducted with an Applied Biosystems 392 DNA/RNA synthesizer
on a 1 µmol scale by using standard phosphoramidite chemistry. The
oligonucleotides were deprotected overnight with a saturated ammonium
hydroxide solution at 60 °C and dried with an Eppendorf Vacufuge.
Chromatographic analysis and preparative HPLC purification of oli-
gonucleotides were performed on a Varian Star HPLC system with a
Hydopore-5-AX 10 × 100 mm SAX column. Buffer A contained 5 M
urea and 20 mM aqueous sodium phosphate, pH 6.5, and buffer B
contained 5 M urea and 1 M (NH4)2SO4 in 20 mM aqueous sodium
phosphate buffer. The rb values, moles of Pt bound per nucleotide
strand, were determined by quantification of platinum using flameless
atomic absorption spectrophotometry (Perkin-Elmer AAnalyst 300
system) and of DNA by UV/vis spectroscopy (Varian Cary 1E
spectrometer). The specific extinction coefficient of each oligonucleotide
was estimated as the sum of the individual extinction coefficients of
the nucleotides in the sequence.41,42 MALDI measurements were
conducted on a Bruker Omniflex mass spectrometer at the Department
of Chemistry Instrumentation Facility (DCIF), Massachusetts Institute
of Technology (MIT), or on an Applied Biosystems Model Voyager
DE-STR mass spectrometer at the MIT CCR Biopolymers Laboratory.
Enzymes were obtained from New England Biolabs (Ipswich, MA)
unless otherwise specified. Enzymatic reactions were carried out in
reaction buffers provided by the supplier unless otherwise noted.
Pelleted HeLa-S3 cells were obtained from the National Cell Culture
Center (Minneapolis, MN). Beckmann-Coulter Avanti J-25 and Optima
L centrifuges were used for chromatin preparation. For chromatin
sonication, a Branson digital sonifier was utilized. All steps involving
Preparation of DNA Duplexes. The oligonucleotides b1, b1-Pt,
b2, b2-Pt, c, d, e1, and e2 were 5′-phosphorylated with T4 polynucle-
otide kinase under standard conditions. A 500 pmol quantity of each
appropriate phosphorylated strand, 1000 pmol of either 21-mer b1, b1-
Pt, b2, or b2-Pt, and oligonucleotides a (500 pmol) and e (1000 pmol)
were annealed in buffer (100 mM NaCl, 70 mM Tris/HCl, pH 7.5, 10
mM MgCl2) by applying a temperature gradient from 90 °C to 4 °C
over 3 h and ligated in situ (50 mM NaCl, 60 mM Tris/HCl, 10 mM
MgCl2, 10 mM DTT, 1.5 mM ATP, 25 µg/mL BSA, 10 U/µL T4 DNA
ligase, 48 h, 16 °C) to give the 171-/173-mer duplex DNA strands R1,
R1-Pt, R2, and R2-Pt as detailed in Scheme S1 (Supporting Informa-
tion). The sample strands were then phenol extracted, ether extracted,
ethanol precipitated, and purified on a 6% denaturing polyacrylamide
gel. The gel pieces were extracted with 50 mM NaCl, 10 mM Tris/
HCl, and 1 mM EDTA, ethanol precipitated, and further purified by
gel filtration chromatography (Probequant G-50 cartridges, GE Health-
care). The eluted DNA was brought to 150 mM NaCl, annealed by
applying a temperature gradient from 90 °C to 4 °C over 3 h, and
concentrated with Nanosep MWCO 10kD cartridges (Pall Corp., East
Hills, NY).
In order to label exclusively the coding strands of the duplexes, 100
pmol samples of all duplexes were overdigested with EcoRV (20 U)
overnight in separate reactions. The strands were dephosphorylated with
Antarctic phosphatase (10 U, 1 h), and the enzymes were removed by
phenol extraction and ethanol precipitation. Next, 20 pmol of the
truncated strands was phosphorylated with 250 µCi γ-32P-ATP per
reaction by using T4 polynucleotide kinase (20 U, 37 °C, 2 h). The
reactions were brought to 20 mM EDTA, the enzyme was heat
deactivated, and the EDTA was removed by gel filtration (Microspin
G-25 cartridges, GE Healthcare). Finally, the strands were overdigested
(40) Dhara, S. C. Indian J. Chem. 1970, 8, 193-194.
(41) Cantor, C. R.; Warshaw, M. M.; Shapiro, H. Biopolymers 1970, 9, 1059-
1077.
(42) Fasman, G. D. Optical Properties of Nucleic Acids, Absorption, and Circular
Dichroism Spectra, 3rd ed.; CRC Press: Cleveland, OH, 1975; Vol. 1.
(43) Wei, M.; Cohen, S. M.; Silverman, A. P.; Lippard, S. J. J. Biol. Chem.
2001, 276, 38774-38780.
9
J. AM. CHEM. SOC. VOL. 130, NO. 9, 2008 2859